His seminar, titled "Cell-Based Immunotherapy for the Treatment of Chronic Inflammation: Fact or Fantasy," will take place Sept. 30, 2010, at 4 p.m. in the Medical Sciences Building auditorium.
Dr. Grisham’s research focuses on intestinal mucosal immunology and regulation of chronic gut inflammation. His research has been continuously funded for the past 20 years by NIH and has been awarded several research grants from the CCFA and Broad Foundation. He has published more than 250 peered-reviewed journal articles and 80 book chapters. In addition, he has edited two books and written one book on the mechanisms of acute and chronic inflammation.
Dr. Grisham received his Ph.D. in biochemistry from Texas Tech University Health Sciences Center and completed his post-doctoral training at St. Jude Children's Research Hospital. In 1984, he moved to the department of biochemistry at the USA College of Medicine where he assumed the position of assistant professor until his relocation to LSU Health Sciences Center in 1987.
Dr. Grisham is an active member of the Grants Review Committee for the Crohn’s and Colitis Foundation of America (CCFA) and for the National Institute of Digestive Diseases and Kidney. He has served as president of the Society for Free Radical Biology and Medicine and served as councilor for the Immunology, Microbiology and Inflammatory Bowel Disease section of the American Gastroenterological Association.
Dr. Grisham recently completed his term as chair of the Gastrointestinal and Liver Section of the American Physiological Society. In addition, he is an associate editor of the American Journal of Physiology and Free Radical Biology and Medicine. He has served or is currently serving on the editorial boards of the following journals: Inflammatory Bowel Disease, the Journal of Immunology and American Journal of Physiology.
For more information on Dr. Grisham’s research, visit http://www.shreveportphysiology.com/fac_matthew_grisham
